FMP
Skye Bioscience, Inc.
SKYE
PNK
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
14.03 USD
-0.78 (-5.56%)
About
ceo
Mr. Punit S. Dhillon B.A., BA
sector
Healthcare
industry
Biotechnology
website
https://skyebioscience.com
exchange
PNK
Description
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
CIK
0001516551
ISIN
US83086J2006
CUSIP
83086J101
Address
11250 El Camino Real
Phone
858 410 0266
Country
US
Employee
11
IPO Date
Nov 26, 2014
Summary
CIK
0001516551
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
83086J101
ISIN
US83086J2006
Country
US
Price
14.03
Beta
0.63
Volume Avg.
39.77k
Market Cap
13.63B
Shares
-
52-Week
1.44-19.41
DCF
-0.34
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.24
P/B
-
Website
https://skyebioscience.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SKYE News
It looks like there's no news available.
